The company, which secured $200 million from investors in a private funding deal last week, learned Tuesday of a serious side ...

If confirmed to the role, Robert F. Kennedy Jr. would oversee the country's top health agencies, including the Food and Drug ...

Kebilidi is the first approved gene therapy that can be directly administered to the brain. Its OK secures a priority review ...

The company is paying China-based biotech LaNova Medicines $588 million for the same type of bispecific antibody drug that ...

A key regulatory committee sided against the drug this summer. But an appeal from Eisai appears to have worked, teeing Leqembi up for authorization in a major market.

Life sciences expert Jennie Taveras has joined STO Building Group to lead the company’s growth in the life sciences sector ...